Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches

By sjmartinez • September 8, 2023

Singh M, Paul MK, Roy S. Editorial: Pharmaceutically targeting hypoxia in the breast cancer microenvironment: mechanistic and translational approaches. Front Oncol. 2023 Aug 23;13:1265523. doi: 10.3389/fonc.2023.1265523. PMID: 37681032; PMCID: PMC10482239.

Tags: breast cancer, drug delivery, HIF-1α, hypoxia, Publications, Pulmonary, Critical Care & Sleep Medicine, tumor microenvironment (TME)

Related Posts

Moderators of the Effects of Telehealth Mindfulness-based Interventions for Chronic Pain: A Secondary Responder Analysis of the LAMP Randomized Controlled Trial

Calvert CM, Hagel Campbell EM, Cross LJS, Bangerter A, Bronfort G, Evans R, Meis LA, Haley A, Leininger B, Matthias M, Polusny M, Allen K,[...]

Leveraging scholarship to lead

Moriates C. Leveraging scholarship to lead. J Hosp Med. 2026 Sep 9. doi: 10.1002/jhm.70478. Epub ahead of print. PMID: 42717657.

Fatty Acid and Oxylipin Metabolism Differentiate Isolated Postcapillary From Combined Pre- and Postcapillary Pulmonary Hypertension

Alotaibi M, Tang A, Sun N, Gurholt I, Yuguchi E, Roberts K, Preston I, Warburton R, Yuan JX, Kim NH, Chan SY, Jain M, Cheng[...]